asfotase alfa 28 MG in 0.7 ML Injection

RxCUI: 1720271
RxNorm name: asfotase alfa 28 MG in 0.7 ML Injection
Display name: asfotase alfa 28 MG in 0.7 ML Injection
Full name: asfotase alfa 28 MG in 0.7 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:53

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125513	Strensiq	asfotase alfa	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
STRENSIQ	ASFOTASE ALFA	Alexion Pharmaceuticals, Inc.	3387574f-5eaa-4501-a71d-4cbfbd563031	2025-12-12	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1720271

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
3387574f-5eaa-4501-a71d-4cbfbd563031	asfotase alfa 28 MG in 0.7 ML Injection	PSN	18	These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015	20251212
3387574f-5eaa-4501-a71d-4cbfbd563031	asfotase alfa 28 MG per 0.7 ML Injection	SY	18	These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015	20251212
3387574f-5eaa-4501-a71d-4cbfbd563031	0.7 ML asfotase alfa 40 MG/ML Injection	SCD	18	These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015	20251212